BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 31559459)

  • 1. Assessment of prognosis in immunoglobulin light chain amyloidosis patients with severe heart failure: a predictive value of right ventricular function.
    Nagano N; Yano T; Fujita Y; Kouzu H; Koyama M; Ikeda H; Yasui K; Muranaka A; Nishikawa R; Takahashi R; Kishiue N; Yuda S; Miura T
    Heart Vessels; 2020 Apr; 35(4):521-530. PubMed ID: 31559459
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic value of right ventricular systolic function in cardiac amyloidosis.
    Bodez D; Ternacle J; Guellich A; Galat A; Lim P; Radu C; Guendouz S; Bergoend E; Couetil JP; Hittinger L; Dubois-Randé JL; Plante-Bordeneuve V; Deux JF; Mohty D; Damy T
    Amyloid; 2016 Sep; 23(3):158-167. PubMed ID: 27348696
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IVC diameter in patients with chronic heart failure: relationships and prognostic significance.
    Pellicori P; Carubelli V; Zhang J; Castiello T; Sherwi N; Clark AL; Cleland JG
    JACC Cardiovasc Imaging; 2013 Jan; 6(1):16-28. PubMed ID: 23328557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of BNP and NT-proBNP in Patients With Heart Failure and Reduced Ejection Fraction.
    Rørth R; Jhund PS; Yilmaz MB; Kristensen SL; Welsh P; Desai AS; Køber L; Prescott MF; Rouleau JL; Solomon SD; Swedberg K; Zile MR; Packer M; McMurray JJV
    Circ Heart Fail; 2020 Feb; 13(2):e006541. PubMed ID: 32065760
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic value of N-terminal pro-type-B natriuretic peptide and Doppler left ventricular diastolic variables in patients with chronic systolic heart failure stabilized by therapy.
    Dini FL; Conti U; Fontanive P; Andreini D; Panicucci E; De Tommasi SM
    Am J Cardiol; 2008 Aug; 102(4):463-8. PubMed ID: 18678307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognosis of Light Chain Amyloidosis With Preserved LVEF: Added Value of 2D Speckle-Tracking Echocardiography to the Current Prognostic Staging System.
    Barros-Gomes S; Williams B; Nhola LF; Grogan M; Maalouf JF; Dispenzieri A; Pellikka PA; Villarraga HR
    JACC Cardiovasc Imaging; 2017 Apr; 10(4):398-407. PubMed ID: 27639764
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tricuspid annular plane systolic excursion and pulmonary arterial systolic pressure relationship in heart failure: an index of right ventricular contractile function and prognosis.
    Guazzi M; Bandera F; Pelissero G; Castelvecchio S; Menicanti L; Ghio S; Temporelli PL; Arena R
    Am J Physiol Heart Circ Physiol; 2013 Nov; 305(9):H1373-81. PubMed ID: 23997100
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimal noninvasive assessment of diastolic heart failure in patients with atrial fibrillation: comparison of tissue doppler echocardiography, left atrium size, and brain natriuretic peptide.
    Watanabe T; Iwai-Takano M; Oikawa M; Yamaki T; Yaoita H; Maruyama Y
    J Am Soc Echocardiogr; 2008 Jun; 21(6):689-96. PubMed ID: 17904810
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Right atrial volume index in chronic systolic heart failure and prognosis.
    Sallach JA; Tang WH; Borowski AG; Tong W; Porter T; Martin MG; Jasper SE; Shrestha K; Troughton RW; Klein AL
    JACC Cardiovasc Imaging; 2009 May; 2(5):527-34. PubMed ID: 19442936
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impaired right ventricular function as a predictor of early mortality in patients with light‑ chain cardiac amyloidosis assessed in a cardiology department.
    Szczygieł JA; Wieczorek PZ; Drozd-Sokołowska J; Michałek P; Mazurkiewicz Ł; Legatowicz-Koprowska M; Walczak E; Jędrzejczak WW; Dwilewicz-Trojaczek J; Grzybowski J
    Pol Arch Intern Med; 2017 Dec; 127(12):854-864. PubMed ID: 29112180
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A new staging system using right atrial strain in patients with immunoglobulin light-chain cardiac amyloidosis.
    Usuku H; Yamamoto E; Sueta D; Shinriki R; Oike F; Tabata N; Ishii M; Hanatani S; Hoshiyama T; Kanazawa H; Arima Y; Takashio S; Kawano Y; Oda S; Kawano H; Ueda M; Tsujita K
    ESC Heart Fail; 2024 Jun; 11(3):1612-1624. PubMed ID: 38400613
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Utility of B-Type Natriuretic Peptide for Detecting Cardiac Involvement in Immunoglobulin Amyloidosis.
    Kimishima Y; Yoshihisa A; Kiko T; Yokokawa T; Miyata-Tatsumi M; Misaka T; Oikawa M; Kobayashi A; Takeishi Y
    Int Heart J; 2019 Sep; 60(5):1106-1112. PubMed ID: 31484874
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of different techniques to identify cardiac involvement in immunoglobulin light chain (AL) amyloidosis.
    Aljama MA; Sidiqi MH; Dispenzieri A; Gertz MA; Lacy MQ; Buadi FK; Dingli D; Muchtar E; Fonder AL; Hayman SR; Hobbs MA; Gonsalves WI; Warsame RM; Kourelis T; Hwa YL; Kapoor P; Leung N; Go RS; Kyle RA; Rajkumar SV; Kumar SK
    Blood Adv; 2019 Apr; 3(8):1226-1229. PubMed ID: 30975646
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Malnutrition, congestion and mortality in ambulatory patients with heart failure.
    Sze S; Pellicori P; Zhang J; Clark AL
    Heart; 2019 Feb; 105(4):297-306. PubMed ID: 30121635
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Global longitudinal strain in patients with suspected heart failure and a normal ejection fraction: does it improve diagnosis and risk stratification?
    Pellicori P; Kallvikbacka-Bennett A; Khaleva O; Carubelli V; Costanzo P; Castiello T; Wong K; Zhang J; Cleland JG; Clark AL
    Int J Cardiovasc Imaging; 2014 Jan; 30(1):69-79. PubMed ID: 24150723
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Right ventricular function in heart failure with preserved ejection fraction: a community-based study.
    Mohammed SF; Hussain I; AbouEzzeddine OF; Takahama H; Kwon SH; Forfia P; Roger VL; Redfield MM
    Circulation; 2014 Dec; 130(25):2310-20. PubMed ID: 25391518
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical correlates and prognostic values of pseudoinfarction in cardiac light-chain amyloidosis.
    Zhao L; Li J; Tian Z; Fang Q
    J Cardiol; 2016 Nov; 68(5):426-430. PubMed ID: 26685729
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical features and predictors of atrial fibrillation in patients with light-chain or transthyretin cardiac amyloidosis.
    Papathanasiou M; Jakstaite AM; Oubari S; Siebermair J; Wakili R; Hoffmann J; Carpinteiro A; Hagenacker T; Thimm A; Rischpler C; Kessler L; Rassaf T; Luedike P
    ESC Heart Fail; 2022 Jun; 9(3):1740-1748. PubMed ID: 35178887
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Usefulness of B-type natriuretic peptide in hypertensive patients with exertional dyspnea and normal left ventricular ejection fraction and correlation with new echocardiographic indexes of systolic and diastolic function.
    Mottram PM; Leano R; Marwick TH
    Am J Cardiol; 2003 Dec; 92(12):1434-8. PubMed ID: 14675580
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Longitudinal systolic strain, cardiac function improvement, and survival following treatment of light-chain (AL) cardiac amyloidosis.
    Salinaro F; Meier-Ewert HK; Miller EJ; Pandey S; Sanchorawala V; Berk JL; Seldin DC; Ruberg FL
    Eur Heart J Cardiovasc Imaging; 2017 Sep; 18(9):1057-1064. PubMed ID: 27965280
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.